HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 72 filers reported holding HARVARD BIOSCIENCE INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $489,000 | -52.3% | 89,472 | -62.6% | 0.39% | +79.2% |
Q4 2020 | $1,026,000 | -62.5% | 239,106 | -73.7% | 0.22% | -51.7% |
Q3 2020 | $2,739,000 | -46.7% | 909,977 | -45.2% | 0.45% | -11.7% |
Q2 2020 | $5,143,000 | +43.7% | 1,659,141 | +2.5% | 0.51% | +35.3% |
Q1 2020 | $3,579,000 | -25.5% | 1,619,393 | +2.9% | 0.37% | +14.0% |
Q4 2019 | $4,801,000 | +13.7% | 1,573,981 | +14.6% | 0.33% | +13.5% |
Q3 2019 | $4,224,000 | +82.8% | 1,373,518 | +18.9% | 0.29% | +50.5% |
Q2 2019 | $2,311,000 | +506.6% | 1,155,376 | +1207.4% | 0.19% | +500.0% |
Q1 2019 | $381,000 | – | 88,369 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Engine Capital Management, LP | 3,542,852 | $10,536,000 | 4.92% |
Fondren Management LP | 865,000 | $2,660,000 | 2.21% |
Harvey Partners, LLC | 742,500 | $2,283,000 | 1.65% |
BARD ASSOCIATES INC | 311,922 | $959,000 | 0.49% |
Adirondack Research & Management Inc. | 131,042 | $403,000 | 0.35% |
Granahan Investment Management | 1,771,964 | $5,449,000 | 0.30% |
DALTON GREINER HARTMAN MAHER & CO | 1,373,518 | $4,224,000 | 0.29% |
HEARTLAND ADVISORS INC | 1,000,000 | $3,075,000 | 0.24% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 499,616 | $1,536,000 | 0.22% |
Alambic Investment Management, L.P. | 43,569 | $134,000 | 0.10% |